Seize on the 2019 spring
Seize on the 2019 spring
Here, at Cremer Consulting, we know all too well how relevant publishing your scientific work is. So don’t let your hard-won research gather dust! The more you publish, the better your chances at reaching new heights in your career.
And throughout the publishing process, we’ll be here to help.
Another paper published in Lancet Oncology
The article by Prof. Arnaud Scherpereel from Lille University Hospitals has been accepted by The Lancet Oncology, Online First, as one of their “fast track” submission choices. The study focused on the role of immune therapy in managing mesothelioma, a serious form of cancer linked to asbestos exposure.
Asbestos is still used today, despite being toxic, and the number of victims suffering from mesothelioma are thus likely to continue to grow. The current treatment options are chemotherapy, radiotherapy, and surgery, albeit with far from satisfactory outcomes. The fact remains that the prognosis of this cancer is still bleak. It is with great relief, then, that new drugs have emerged in immune therapy, such as nivolumab and ipilimumab, which could potentially change bleak to bright. This is what Prof Scherpereel concludes at the end of his study.
At the 2017 ASCO congress, Prof Arnaud Sherpereel presented the preliminary results of his study. Comparing two different immune therapy regimes, nivolumab alone or nivolumab + ipilimumab, he assessed approximately 100 patients suffering from advanced mesothelioma. The time until cancer progression was 4 months for those receiving nivolumab, compared with 5.6 months for those receiving the combination treatment. As for toxicity, more undesirable effects, of greater severity, were observed in patients given the combination.
We are absolutely delighted for this latest successful publication! You, too, can trust your work to us, and it doesn’t matter whether you’ve nearly finished the publication process or barely started, either. We can manage the entire project from start to finish, or just help out with one or several steps, as our successful collaboration with Prof Arnaud Scherpereel and his colleagues attests!
The celebrities that have passed through Strasbourg
To really get a feel for Strasbourg, a picturesque city with a sometimes turbulent history, you need to take your time. It’s the sort of place where getting lost is a virtue, letting you look around and really explore. More than a few celebrities have lost themselves in this unique city’s charms over the centuries, too…
Johann Wolfgang von Goethe is among the most famous people to have studied at Strasbourg University. He came to continue his legal studies at Strasbourg’s law school after taking up law in Leipzig. It was while staying upstairs in a narrow half-timbered Strasbourg house that a young Goethe celebrated his 21st birthday, right in the center overlooking what is now a bustling street of bars and shops. While living in the Alsace capital, he fell madly in love with Frédérique, the young daughter of the pastor of the nearby village of Sessenheim. It was not enough to keep him here, though, and he left Alsace with just a law degree to show for his short time, his doctorate thesis having been well and truly rejected.
At the end of the summer of 1778, another celebrity visited Strasbourg – Wolfgang Amadeus Mozart. On his way back to Salzburg from Versailles, he spent 3 weeks in the city during which, according to legend, he gave many concerts, notably in the concert hall now named “Salle Mozart”. Situated near place Gutenberg, the hall has since been completely renovated, but one can still sense the genius of the great musician emanating from its stage.
From 1848 to 1854, Louis Pasteur was a Professor at the School of Pharmacy at Strasbourg University, and it was in this very city that he married the University Rector’s daughter. During his time here, and throughout his career afterwards, he made some of the greatest contributions to modern medicine, inventing pasteurization, highlighting the role of microbes, and promoting the practice of sterilization.
Medical translation pitfalls
First-quality medical translations require specialized knowledge in the medical field, a good understanding of the source language, in addition to proficiency in the target language. Becoming a good medical translator isn’t an easy journey, with many pitfalls on the way.
One of the problems encountered by medical translators is the common use of abbreviations and acronyms in medical texts. While many of these acronyms are not internationally recognized, others may have several different meanings. As a result, the translator is often obliged to carry out investigational research to grasp the acronyms’ correct meaning.
Needless to say, finding out and selecting the accurate names for multiple medical conditions, as well as the original names of chemical compounds (generic vs. brand names), requires thorough research and there is no room for error. Perhaps the most challenging hurdle in scientific papers is the common use of medical
jargon. Why do physicians use so much jargon? Who knows? Maybe using coded words helps healthcare professionals establish a needed distance between themselves and other hospital staff, and the patients as well. Perhaps it gives them the feeling of truly belonging to the healthcare profession.
A last point to highlight is that most medical papers are often in bad shape, with poor syntax, grammar, and numerous missing words, which doesn’t facilitate the task of the medical translator. The fact is that most medical doctors have not been trained in effective communication skills. In conclusion, becoming a first-class medical translator is a fascinating journey, but requires hard work.